表紙
市場調査レポート

スマートピルの世界市場予測 2024年:カプセル内視鏡・ドラッグデリバリー・患者モニタリング

Smart Pills Market by Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring), Target Area (Esophagus, Stomach, Small Intestine, Large Intestine) & Geography - Global Forecast to 2024

発行 MarketsandMarkets 商品コード 253270
出版日 ページ情報 英文 127 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.69円で換算しております。
Back to Top
スマートピルの世界市場予測 2024年:カプセル内視鏡・ドラッグデリバリー・患者モニタリング Smart Pills Market by Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring), Target Area (Esophagus, Stomach, Small Intestine, Large Intestine) & Geography - Global Forecast to 2024
出版日: 2015年03月25日 ページ情報: 英文 127 Pages
概要

ライフスタイルや食習慣の変化、高齢化などにより、胃腸障害は私たちの日々の生活にますます広く浸透しています。しかし、いくつかの胃腸障害については、小腸の輪郭に達する効果的な医療機器の不足から、依然として有効な治療法も出血の原因も解明されていません。柔軟性の高い内視鏡は幾つかあるものの、体内へのチューブの挿入に患者は不快感を示しています。その中で、医療科学および技術の進化とマイクロ技術・ナノ技術の出現により、小型の無線カプセル内視鏡が開発されました。これらの機器はピンポイントの薬剤送達や効果的な患者のモニタリングにも用いられています。バイオMEMSによって実現したこの新しいアプローチはスマートピルと呼ばれ、患者に快適性をもたらすだけでなく、医療プロバイダーによるオンタイムでの効果的な治療の実行も可能にしています。

当レポートでは、スマートピル技術市場の現状と見通しについて調査分析し、スマートピルの技術と用途、用途別の発展の経緯・技術動向・導入エリア・成長推進因子/阻害因子などの分析、スマートピル技術ベースのデバイス市場の推移と予測、技術開発のロードマップ、投資・資金調達環境の分析、地域別の動向、アナリストによる提言、主要企業のプロファイルなどをまとめ、概略以下の構成でお届けいたします。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 スマートピル:技術概要

  • スマートピル技術:概要
  • カプセル内視鏡 (カメラピル技術)
    • これまでの経緯:概要
    • 技術動向
    • 導入領域
  • 胃腸のモニタリングのためのスマートピル技術
    • これまでの経緯:概要
    • 技術動向
    • 導入領域
  • スマートピルによる薬剤送達システム
    • これまでの経緯:概要
    • 技術動向
    • 導入領域

第4章 技術動向分析

  • スマートピル技術の用途:ロードマップ
  • 技術バリューチェーン分析
    • スマートピル:バリューチェーン
    • バリューチェーンにおけるギャップのリスト
    • スマートピル市場のバリューチェーン強化のための戦略候補
  • 技術動向・スマートピルの導入の可能性

第5章 スマートピルの市場環境分析

  • 市場規模:潜在的アドレサブル市場
  • 世界市場予測
  • カメラピル技術
    • 主な技術面・事業面の成長推進因子
    • 成長阻害因子・課題
  • スマートピル技術ベースのGIモニタリングシステム:市場力学
    • 主な技術面・事業面の成長推進因子
    • 成長阻害因子・課題
  • スマートピルベースの薬剤送達システム:市場力学
    • 主な技術面・事業面の成長推進因子
    • 成長阻害因子・課題
  • 新しい技術動向
  • スマートピル:PESTLE分析

第6章 投資家分析・投資機会

  • 投資家ネットワーク
    • スマートピル技術への連邦政府補助金
    • 公共資金供給団体
    • 機関投資家・個人投資家
  • 技術インキュベーター
    • 政府/連邦技術インキュベーター
    • 企業技術インキュベーター
  • 資金供給パターン・投資家の傾向
  • 現在および将来の技術投資機会に関する考察
    • ライセンシング・買収に利用可能な技術の評価
    • 技術投資の潜在的導入領域の分析
  • AHPベースのスマートピル技術のポートフォリオ分析

第7章 スマートピル市場の地域分析

  • 南北アメリカ
    • 北米
    • 南米
  • 欧州
  • 中東・アフリカ
  • アジア太平洋

第8章 競合環境

  • M&A
  • 提携・協力
  • 技術ベースのイニシアチブ

第9章 アナリストによる考察・提言

  • ディベロッパーのスマートスカウティングおよび資金調達のための戦略的提言
  • 開かれた市場機会

第10章 企業プロファイル

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MD 3264

The healthcare industry is witnessing a paradigm shift from traditional devices to more sophisticated and programmed ones. Growing demand for noninvasive procedures, sophisticated drug delivery techniques, and improved patient monitoring solutions are propelling the growth of this market. Companies are increasingly focusing on investing in R&D activities for the development of the smart pills technology in order to meet consumer expectations and to help in the treatment of various diseases.

The smart pills market is segmented on the basis of applications and regions. On the basis of applications, capsule endoscopy accounted for the largest share of the smart pills market in 2014. On the basis of regions, North America is expected to grow at the highest CAGR during the forecast period. The high growth of this region can be attributed to the favorable reimbursement scenario, FDA approvals for smart pills, and investment by government and other agencies.

The smart pills market has few players as two major segments of the market are under R&D phase. The companies in this market focus on growth strategies such as new product launches; agreements, partnerships, collaborations, and others (approvals and expansion) to increase their customer base.

The major players in the global smart pills market include CapsoVision, Inc. (U.S.), Given Imaging, Inc. (Israel), Medimetrics S.A. de C.V. (Mexico), Olympus Corporation (Japan), and Bio-Images Research Limited (U.K.).

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios and services offered by the 10 major players in the smart pills market. The report analyzes the smart pills technology across geographies
  • Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and new product launches in the smart pills market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the smart pills market across geographies
  • Market Diversification: Extensive information about new products and services, untapped geographies, recent developments, and investments in the smart pills market
  • Competitive Assessment: In-depth assessment of strategies, products, and services of the leading players in the smart pills market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY & PRICING
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.1.1. SECONDARY RESEARCH
    • 2.1.2. KEY DATA FROM SECONDARY SOURCES
    • 2.1.3. PRIMARY RESEARCH
      • 2.1.3.1. Key data from primary sources
      • 2.1.3.2. Key insights from primary sources
  • 2.2. MARKET SIZE ESTIMATION METHODOLOGY
    • 2.2.1. MARKET FORECAST METHODOLOGY
    • 2.2.2. MARKET DATA VALIDATION AND TRIANGULATION
    • 2.2.3. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. ATTRACTIVE MARKET OPPORTUNITIES IN THE SMART PILLS MARKET
  • 4.2. GLOBAL SMART PILLS MARKET, BY APPLICATION
  • 4.3. GROWTH RATE ACROSS GEOGRAPHIES
  • 4.4. SMART PILLS MARKET: LIFE CYCLE ANALYSIS, BY GEOGRAPHY

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
    • 5.2.1. SMART PILLS MARKET, BY APPLICATION
    • 5.2.2. SMART PILLS MARKET, BY GEOGRAPHY
  • 5.3. MARKET DYNAMICS
  • 5.4. DRIVERS
    • 5.4.1. FAVORABLE REIMBURSEMENT SCENARIO
    • 5.4.2. PATIENT PREFERENCE FOR MINIMALLY INVASIVE SURGERIES
    • 5.4.3. TECHNOLOGICAL ADVANCEMENTS IN CAPSULE ENDOSCOPES
    • 5.4.4. INCREASE IN INCIDENCE OF COLON CANCER
    • 5.4.5. BOWEL SCOPE SCREENING IS EXPECTED TO HAVE A POSITIVE IMPACT ON THE ENDOSCOPY MARKET IN THE U.K.
    • 5.4.6. GROWTH IN AGING POPULATION
  • 5.5. RESTRAINTS
    • 5.5.1. TECHNOLOGICAL LIMITATIONS IN TERMS OF TAKING IMAGES OF A PARTICULAR SITE AND RETENTION OF CAPSULE
    • 5.5.2. INCREASING TECHNOLOGICAL SOPHISTICATION IN SMART PILLS TO INCREASE THEIR COST
  • 5.6. OPPORTUNITIES
    • 5.6.1. NEED FOR A RAPID DRUG DEVELOPMENT PROCESS
  • 5.7. PORTER'S FIVE FORCES ANALYSIS
    • 5.7.1. THREAT OF NEW ENTRANTS
    • 5.7.2. THREAT OF SUBSTITUTES
    • 5.7.3. BARGAINING POWER OF BUYERS
    • 5.7.4. BARGAINING POWER OF SUPPLIERS
    • 5.7.5. INTENSITY OF COMPETITIVE RIVALRY

6. SMART PILLS TECHNOLOGY MARKET, BY APPLICATION

  • 6.1. INTRODUCTION
  • 6.2. CAPSULE ENDOSCOPES
    • 6.2.1. OVERVIEW
    • 6.2.2. CAPSULE ENDOSCOPES: COMPONENTS
      • 6.2.2.1. Components
    • 6.2.3. PILLCAM COLON BY GIVEN IMAGING
      • 6.2.3.1. Interactive colon exam comparison tool
    • 6.2.4. CURRENTLY MARKETED PRODUCTS WITH SPECIFICATIONS
    • 6.2.5. CAPSULE ENDOSCOPES MARKET SIZE
  • 6.3. SMART PILLS FOR PATIENT MONITORING
    • 6.3.1. SMART PILLS FOR PATIENT MONITORING: OVERVIEW
    • 6.3.2. PROTEUS DIGITAL HEALTH
    • 6.3.3. SMART PILLS FOR PATIENT MONITORING: MARKET SIZE
    • 6.3.4. SMART PILLS FOR PATIENT MONITORING: FUTURE POTENTIAL
  • 6.4. SMART PILLS FOR DRUG DELIVERY
    • 6.4.1. SMART PILLS FOR DRUG DELIVERY: OVERVIEW
    • 6.4.2. INTELLICAP SYSTEM BY MEDIMETRICS
    • 6.4.3. SMART PILLS FOR DRUG DELIVERY: MARKET SIZE
    • 6.4.4. SMART PILLS FOR DRUG DELIVERY: FUTURE POTENTIAL

7. RESEARCH LANDSCAPE

  • 7.1. THE MELODY PROJECT
  • 7.2. EDIBLE BATTERY TO TARGET HEALTH SENSORS AND DRUG DELIVERY
  • 7.3. LASER PILL FOR ESOPHAGUS IMAGING
  • 7.4. MAARS REMOTE-CONTROLLED MAGNETIC CAPSULE
  • 7.5. DESIGN AND IMPLEMENTATION OF MINIATURIZED CAPSULES FOR AUTO-FLUORESCENCE DETECTION WITH POSSIBLE APPLICATIONS IN BOWEL DISEASE
  • 7.6. DETECTING A SECRETED GASTRIC CANCER BIOMARKER MOLECULE BY TARGETED NANOPARTICLES FOR REAL-TIME DIAGNOSTICS
  • 7.7. MAGNETICALLY ACTUATED SOFT CAPSULE ENDOSCOPE (MASCE)
  • 7.8. POWER GENERATION TECHNOLOGY USING BENDABLE THIN FILM NANO-MATERIALS
  • 7.9. WIRELESSLY COMMUNICATING CAPSULE PROTOTYPE
  • 7.10. DEVELOPMENT OF CMOS SENSORS FOR INCORPORATION IN ENDOSCOPIC CAPSULES FOR CANCER CELLS
  • 7.11. VERSATILE ENDOSCOPIC CAPSULE FOR GASTROINTESTINAL TUMOR RECOGNITION AND THERAPY: VECTOR
  • 7.12. NOVEL, INNOVATIVE, REMOTE-CONTROLLED DRUG DELIVERY CAPSULE
  • 7.13. DRUG DELIVERY WITH MUSCLE

8. SMART PILLS MARKET, BY REGION

  • 8.1. INTRODUCTION
  • 8.2. NORTH AMERICA
    • 8.2.1. U.S.
    • 8.2.2. CANADA
  • 8.3. EUROPE
    • 8.3.1. U.K.
    • 8.3.2. SPAIN
    • 8.3.3. GERMANY
    • 8.3.4. FRANCE
    • 8.3.5. ITALY
    • 8.3.6. REST OF EUROPE
  • 8.4. ASIA
    • 8.4.1. JAPAN
    • 8.4.2. CHINA
    • 8.4.3. INDIA
    • 8.4.4. REST OF ASIA (ROA)
  • 8.5. REST OF THE WORLD (ROW)
  • 8.6. PEST ANALYSIS
    • 8.6.1. POLITICAL FACTORS
    • 8.6.2. ECONOMIC FACTORS
    • 8.6.3. SOCIAL FACTORS
    • 8.6.4. TECHNOLOGICAL FACTORS

9. COMPETITIVE LANDSCAPE

  • 9.1. OVERVIEW
  • 9.2. R&D INVESTMENT ANALYSIS, SMART PILLS MARKET
  • 9.3. COMPETITIVE SITUATION AND TRENDS
    • 9.3.1. AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
    • 9.3.2. NEW PRODUCT LAUNCHES
  • 9.4. EXPANSIONS
  • 9.5. OTHER DEVELOPMENTS
  • 9.6. MERGERS AND ACQUISITIONS

10. COMPANY PROFILES

  • 10.1. ACAMP
    • 10.1.1. BUSINESS OVERVIEW
    • 10.1.2. ACAMP: COMPANY SNAPSHOT
    • 10.1.3. PRODUCT PORTFOLIO
  • 10.2. BIO-IMAGES RESEARCH LTD.
    • 10.2.1. BUSINESS OVERVIEW
    • 10.2.2. SERVICE OFFERINGS
    • 10.2.3. RECENT DEVELOPMENTS
  • 10.3. BOSTON SCIENTIFIC CORPORATION
    • 10.3.1. BUSINESS OVERVIEW
    • 10.3.2. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
    • 10.3.3. KEY STRATEGY
      • 10.3.3.1. Focus on research and development:
  • 10.4. CAPSOVISION, INC.
    • 10.4.1. BUSINESS OVERVIEW
    • 10.4.2. PRODUCT PORTFOLIO
    • 10.4.3. KEY STRATEGY
      • 10.4.3.1. Market development:
    • 10.4.4. RECENT DEVELOPMENTS
  • 10.5. GIVEN IMAGING, INC.
    • 10.5.1. BUSINESS OVERVIEW
    • 10.5.2. MEDTRONIC, INC.: COMPANY SNAPSHOT
    • 10.5.3. PRODUCT PORTFOLIO:
    • 10.5.4. KEY STRATEGY
      • 10.5.4.1. FDA Approvals:
    • 10.5.5. RECENT DEVELOPMENTS
  • 10.6. MEDIMETRICS S.A. DE C.V.
    • 10.6.1. BUSINESS OVERVIEW
    • 10.6.2. PRODUCTS AND SERVICES
    • 10.6.3. KEY STRATEGY
      • 10.6.3.1. Partnerships and collaborations:
    • 10.6.4. RECENT DEVELOPMENTS
  • 10.7. OLYMPUS CORPORATION
    • 10.7.1. BUSINESS OVERVIEW
    • 10.7.2. OLYMPUS CORPORATION: COMPANY SNAPSHOT
    • 10.7.3. PRODUCT PORTFOLIO
    • 10.7.4. KEY STRATEGY
      • 10.7.4.1. New Product Launches
    • 10.7.5. RECENT DEVELOPMENTS
  • 10.8. PROTEUS DIGITAL HEALTH, INC.
    • 10.8.1. BUSINESS OVERVIEW
    • 10.8.2. PRODUCT PORTFOLIO
    • 10.8.3. KEY STRATEGY
      • 10.8.3.1. Partnerships and Collaborations
    • 10.8.4. RECENT DEVELOPMENTS

11. APPENDIX

  • 11.1. INSIGHTS OF INDUSTRY EXPERTS
  • 11.2. DISCUSSION GUIDE
  • 11.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 11.4. AVAILABLE CUSTOMIZATIONS
  • 11.5. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: INCREASING INCIDENCE OF THE CANCERS IN MEN GLOBALLY DRIVES THE SMART PILL MARKET
  • TABLE 2: INCREASING INCIDENCE OF THE CANCERS IN WOMEN GLOBALLY DRIVES THE SMART PILL MARKET
  • TABLE 3: COLORECTAL CANCER: ESTIMATED INCIDENCE, MORTALITY AND PREVALENCE WORLDWIDE IN 2012
  • TABLE 4: COUNTRIES WITH HIGHEST INCIDENCE OF COLORECTAL CANCER IN 2012 (BOTH SEXES)
  • TABLE 5: SMART PILLS MARKET SIZE, BY APPLICATION, 2014-2024 ($MILLION)
  • TABLE 6: SMART PILLS MARKET SIZE FOR CAPSULE ENDOSCOPES, BY REGION, 2014-2024 ($MILLION)
  • TABLE 7: CAPSULE ENDOSCOPES MARKET SIZE FOR SMALL INTESTINE, BY REGION, 2014-2024 ($MILLION)
  • TABLE 8: CAPSULE ENDOSCOPES MARKET SIZE FOR COLON, BY REGION, 2014-2024 ($ MILLION)
  • TABLE 9: CAPSULE ENDOSCOPES MARKET SIZE FOR OTHER CAPSULE ENDOSCOPY, BY REGION, 2014-2024 ($ MILLION)
  • TABLE 10: SMART PILLS MARKET SIZE FOR PATIENT MONITORING, BY REGION, 2014-2024 ($MILLION)
  • TABLE 11: SMART PILLS MARKET SIZE FOR DRUG DELIVERY, BY REGION, 2014-2024 ($MILLION)
  • TABLE 12: SMART PILLS MARKET SIZE, BY REGION, 2012-2024 ($MILLION)
  • TABLE 13: NORTH AMERICA: SMART PILLS MARKET SIZE, BY APPLICATION, 2012-2024 ($MILLION)
  • TABLE 14: NORTH AMERICA: SMART PILLS MARKET SIZE, BY COUNTRY, 2012-2024 ($MILLION)
  • TABLE 15: NORTH AMERICA: CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2012-2024 ($MILLION)
  • TABLE 16: NORTH AMERICA: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012-2024 ($MILLION)
  • TABLE 17: NORTH AMERICA: DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2012-2024 ($MILLION)
  • TABLE 18: NORTH AMERICA: PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2012-2024 ($MILLION)
  • TABLE 19: US: SMART PILLS MARKET SIZE, BY APPLICATION, 2012-2024 ($MILLION)
  • TABLE 20: US: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012-2024 ($MILLION)
  • TABLE 21: CANADA: SMART PILLS MARKET SIZE, BY APPLICATION, 2012-2024 ($MILLION)
  • TABLE 22: CANADA: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012-2024 ($MILLION)
  • TABLE 23: EUROPE: SMART PILLS MARKET SIZE, BY APPLICATION, 2012-2024 ($MILLION)
  • TABLE 24: EUROPE: SMART PILLS MARKET SIZE, BY COUNTRY/REGION, 2012-2024 ($MILLION)
  • TABLE 25: EUROPE: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012-2024 ($MILLION)
  • TABLE 26: EUROPE: CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY/REGION, 2014-2024 ($MILLION)
  • TABLE 27: EUROPE: DRUG DELIVERY MARKET SIZE, BY COUNTRY/REGION, 2012-2024 ($MILLION)
  • TABLE 28: EUROPE: PATIENT MONITORING MARKET SIZE, BY COUNTRY/REGION, 2012-2024 ($MILLION)
  • TABLE 29: UK: SMART PILLS MARKET SIZE, BY APPLICATION, 2012-2024 ($MILLION)
  • TABLE 30: UK: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012-2024 ($MILLION)
  • TABLE 31: SPAIN: SMART PILLS MARKET SIZE, BY APPLICATION, 2012-2024 ($MILLION)
  • TABLE 32: SPAIN: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012-2024 ($MILLION)
  • TABLE 33: GERMANY: SMART PILLS MARKET SIZE, BY APPLICATION, 2012-2024 ($MILLION)
  • TABLE 34: GERMANY: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012-2024 ($MILLION)
  • TABLE 35: FRANCE: SMART PILLS MARKET SIZE, BY APPLICATION, 2012-2024 ($MILLION)
  • TABLE 36: FRANCE: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012-2024 ($MILLION)
  • TABLE 37: ITALY: SMART PILLS MARKET SIZE, BY APPLICATION, 2012-2024 ($MILLION)
  • TABLE 38: ITALY: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012-2024 ($MILLION)
  • TABLE 39: ROE: SMART PILLS MARKET SIZE, BY APPLICATION, 2012-2024 ($MILLION)
  • TABLE 40: ROE: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012-2024 ($MILLION)
  • TABLE 41: ASIA: SMART PILLS MARKET SIZE, BY APPLICATION, 2012-2024 ($MILLION)
  • TABLE 42: ASIA: SMART PILLS MARKET SIZE, BY COUNTRY/REGION, 2012-2024 ($MILLION)
  • TABLE 43: ASIA: CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY/REGION, 2012-2024 ($MILLION)
  • TABLE 44: ASIA: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012-2024 ($MILLION)
  • TABLE 45: ASIA: DRUG DELIVERY MARKET SIZE, BY COUNTRY/REGION, 2012-2024 ($MILLION)
  • TABLE 46: ASIA: PATIENT MONITORING MARKET SIZE, BY COUNTRY/REGION, 2012-2024 ($MILLION)
  • TABLE 47: JAPAN: SMART PILLS MARKET SIZE, BY APPLICATION, 2012-2024 ($MILLION)
  • TABLE 48: JAPAN: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012-2024 ($MILLION)
  • TABLE 49: CHINA: SMART PILLS MARKET SIZE, BY APPLICATION, 2012-2024 ($MILLION)
  • TABLE 50: CHINA: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012-2024 ($MILLION)
  • TABLE 51: INDIA: SMART PILLS MARKET SIZE, BY APPLICATION, 2012-2024 ($MILLION)
  • TABLE 52: INDIA: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012-2024 ($MILLION)
  • TABLE 53: ROA: SMART PILLS MARKET SIZE, BY APPLICATION, 2012-2024 ($MILLION)
  • TABLE 54: ROA: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012-2024 ($MILLION)
  • TABLE 55: ROW: SMART PILLS MARKET SIZE, BY APPLICATION, 2012-2024 ($MILLION)
  • TABLE 56: ROW: SMART PILLS MARKET SIZE, BY REGION, 2012-2024 ($MILLION)
  • TABLE 57: ROW: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012-2024 ($MILLION)
  • TABLE 58: ROW: CAPSULE ENDOSCOPY MARKET SIZE, BY REGION, 2012-2024 ($MILLION)
  • TABLE 59: ROW: DRUG DELIVERY MARKET SIZE, BY REGION, 2012-2024 ($MILLION)
  • TABLE 60: ROW: PATIENT MONITORING MARKET SIZE, BY REGION, 2012-2024 ($MILLION)
  • TABLE 61: LATIN AMERICA: SMART PILLS MARKET SIZE, BY APPLICATION, 2012-2024 ($MILLION)
  • TABLE 62: LATIN AMERICA: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012-2024 ($MILLION)
  • TABLE 63: PACIFIC COUNTRIES: SMART PILLS MARKET SIZE, BY APPLICATION, 2012-2024 ($MILLION)
  • TABLE 64: PACIFIC COUNTRIES: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012-2024 ($MILLION)
  • TABLE 65: MIDDLE EAST & AFRICA: SMART PILLS MARKET SIZE, BY APPLICATION, 2012-2024 ($MILLION)
  • TABLE 66: MIDDLE EAST & AFRICA: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012-2024 ($MILLION)
  • TABLE 67: AGREEMENTS AND COLLABORATIONS, 2012-2014
  • TABLE 68: NEW PRODUCT LAUNCHES, 2012-2014
  • TABLE 69: EXPANSIONS, 2012-2014
  • TABLE 70: OTHER DEVELOPMENTS, 2012-2014
  • TABLE 71: MERGERS AND ACQUISITIONS, 2012-2014
  • TABLE 72: EXCHANGE RATES (USED FOR CONVERSION OF YEN TO USD)

LIST OF FIGURES

  • FIGURE 1: SMART PILLS MARKET SEGMENTATION
  • FIGURE 2: RESEARCH METHODOLOGY DESIGN
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 6: MARKET FORECAST METHODOLOGY
  • FIGURE 7: DATA TRIANGULATION METHODOLOGY
  • FIGURE 8: ROW TO WITNESS THE HIGHEST GROWTH RATE IN THE CAPSULE ENDOSCOPY MARKET FROM 2014 TO 2024
  • FIGURE 9: SMART PILLS MARKET SIZE, BY REGION(2014)
  • FIGURE 10: SMART PILLS MARKET SIZE, BY APPLICATION (2014 VS. 2024)
  • FIGURE 11: SMART PILLS MARKET TO GROW AT A CAGR OF 16% FROM 2014 TO 2020, CAGR OF 23% FROM 2020 TO 2024
  • FIGURE 12: CAPSULE ENDOSCOPY SEGMENT COMMANDED THE LARGEST SHARE OF THE GLOBAL SMART PILLS MARKET, 2014
  • FIGURE 13: ROW TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD (2020-2024)
  • FIGURE 14: ROW MARKET TO WITNESS HIGHEST GROWTH IN THE NEAR FUTURE(2020-2024)
  • FIGURE 15: SMART PILLS MARKET SEGMENTATION, BY APPLICATION
  • FIGURE 16: SMART PILLS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
  • FIGURE 17: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 18: CAPSULE ENDOSCOPES DOMINATION IN THE SMART PILLS MARKET IN 2014 VS 2020
  • FIGURE 19: ROW HAS HIGHEST GROWTH IN THE FORECASTED PERIOD 2014-2020 ($MILLION)
  • FIGURE 20: NORTH AMERICAN MARKET TO WITNESS THE HIGHEST CAGR
  • FIGURE 21: CAPSULE ENDOSCOPY SEGMENT TO DOMINATE THE MARKET IN THE FORECAST PERIOD
  • FIGURE 22: COMPANIES ADOPTED AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS AS THEIR KEY GROWTH STRATEGY OVER THE LAST THREE YEARS
  • FIGURE 23: SMART PILLS MARKET: R&D EXPENDITURE SHARE, BY KEY PLAYER, 2014
  • FIGURE 24: BATTLE FOR MARKET SHARE: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS WAS THE KEY GROWTH STRATEGY
  • FIGURE 25: GEOGRAPHICAL PRESENCE OF THE TOP PLAYERS OF THE SMART PILLS MARKET
Back to Top